Background The immune system interacts with cancer cells in various intricate ways that can
protect the individual from overproliferation of cancer cells; however, these interactions can …

The liposome is the first nanomedicine transformed into the market and applied to human
patients. Since then, such phospholipid bilayer vesicles have undergone technological …

Immunotherapy has become an important part of the oncotherapy arsenal. Its applicability in
various cancer types is impressive, as well as its use of endogenous mechanisms to achieve …

Lipid-based nanoparticles (LBNPs) are an important tool for the delivery of a diverse set of
drug cargoes, including small molecules, oligonucleotides, and proteins and peptides …

Long non-coding RNAs (lncRNAs) have been in the spotlight for the past two decades due
to their extensive role in regulating a wide range of cellular processes. Development …

Amid the rise of antibiotic-resistant bacterial strains in human populations, novel solutions
are necessary. Nanoparticles, renowned for their adaptability, offer a diverse range of …

Cancer immunotherapy has made breakthrough progress in cancer treatment. However,
only a subset of patients benefits from immunotherapy. Given their unique structure …

The increasing prevalence of cancer drug resistance not only critically limits the efficiency of
traditional therapies but also causes relapses or recurrences of cancer. Consequently, there …

Purpose: Melittin (MPI) is a potential anticancer peptide due to its abilities of antitumor and
immunomodulatory functions. Epigallocatechin-3-Ogallate (EGCG), a major extract of green …

Gastric cancer (GC) is the fifth most common cancer worldwide, particularly prevalent in
Asia, especially in China, where both its incidence and mortality rates are significantly high …